Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa SC vs IV for Anemia in Non-myeloid Malignancies
NCT00035607Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2001
- Primary completion
- Dec 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Dec 2001; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00035607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035607.